drugset / Trial / NCT02137096

Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma

NCT02137096

Phase 3 Terminated 1 enrolled University of Florida
NaSingle-groupOpen-labelTreatment

Summary

This is a pilot study to evaluate the response rates for patients undergoing high dose conditioning chemotherapy using Etoposide, Carboplatin and Ifosfamide followed by autologous stem cell transplantation for the treatment of recurrent Nasopharyngeal Cancer (NPC) in children, adolescents, and young adults.

Timeline

Start
2014-06
Primary completion
2017-05-09
Completion
2017-05-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule
Subject Etoposide Small molecule
Subject Ifosfamide Small molecule